推薦產品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 萬豐奧威發(fā)布2020年度業(yè)績快報公告，公告顯示，2020年1-12月營業(yè)總收入為10,710,142,381.74元，比上年同期下滑15.45%；歸屬于上市公司股東的凈利潤為557,951,586.49元，比上年同期下滑37.57%。
公告顯示，萬豐奧威總資產為15,916,692,711.07元，比本報告期初下滑13.77%；基本每股收益為0.26元，上年同期為0.41元。
公司2020年度實現(xiàn)營業(yè)總收入10,710,142,381.74元，較上年同期追溯調整前、追溯調整后分別下降0.72%和15.45%；實現(xiàn)歸屬于上市公司股東的凈利潤為557,951,586.49元，較上年同期追溯調整前、追溯調整后分別下降27.47%和37.57%。
2020年公司收購萬豐飛機工業(yè)有限公司55%股權，形成汽車金屬輕量化零部件產業(yè)和通航飛機制造產業(yè)“雙引擎”格局。其中，汽車金屬輕量化零部件產業(yè)受到新冠疫情和中美貿易摩擦外部環(huán)境負面影響較大。公司根據疫情變化積極有序開展復工復產，加強員工培訓和實施降本增效，同時主動應對貿易關稅問題，梳理產業(yè)發(fā)展規(guī)劃，強化客戶交流，調整業(yè)務結構，較為有效的減少了經營業(yè)績下滑，增強了后續(xù)發(fā)展動力。通航飛機制造產業(yè)也一定程度受到新冠疫情影響，集中體現(xiàn)在國外飛機訂單驗收交貨和收入確認延遲。公司根據疫情情況加強同所在國家政府部門交流，有序安排工廠生產，穩(wěn)步推進新機型的研發(fā)和上市推廣，積極開展飛機整機和零部件授權業(yè)務，突破國內飛機制造工廠大批量生產和銷售，減少國外交貨延遲對經營業(yè)績的影響，在外部環(huán)境不利情況下實現(xiàn)了飛機制造產業(yè)經營業(yè)績較大幅度的增長，保持了公司可持續(xù)發(fā)展。
